These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29509176)

  • 1. Relationship Between Antipsychotic Medications and Cerebrovascular Disease in Patients With Serious Mental Illness.
    Berrocal-Izquierdo N; Bioque M; Bernardo M
    J Psychiatr Pract; 2018 Mar; 24(2):72-78. PubMed ID: 29509176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice.
    Jakobs KM; Posthuma A; de Grauw WJC; Schalk BWM; Akkermans RP; Lucassen P; Schermer T; Assendelft WJJ; Biermans MJC
    BMC Fam Pract; 2020 Jul; 21(1):153. PubMed ID: 32727372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Screening among Antipsychotic-Treated Adults with Severe Mental Illness in an Integrated Delivery System: A Retrospective Cohort Study.
    Mangurian C; Schillinger D; Newcomer JW; Vittinghoff E; Essock S; Zhu Z; Dyer W; Schmittdiel J
    J Gen Intern Med; 2018 Jan; 33(1):79-86. PubMed ID: 29090381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is cerebrovascular disease a silent condition in patients with chronic schizophrenia-related disorders?
    Berrocal-Izquierdo N; Bioque M; Bernardo M
    Int Clin Psychopharmacol; 2017 Mar; 32(2):80-86. PubMed ID: 27755155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Disease Mortality of Medicaid Clients with Severe Mental Illness and a Co-occurring Substance Use Disorder.
    Bruckner TA; Yoon J; Gonzales M
    Adm Policy Ment Health; 2017 Mar; 44(2):284-292. PubMed ID: 26874955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of care for cardiovascular disease and diabetes amongst individuals with serious mental illness and those using antipsychotic medications.
    Scott D; Platania-Phung C; Happell B
    J Healthc Qual; 2012; 34(5):15-21. PubMed ID: 22092725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antipsychotic medication on psychiatric service utilization and cost.
    Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
    J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the utility of atypical antipsychotic medication in adults with mild mental retardation and comorbid psychiatric disorders.
    Shedlack KJ; Hennen J; Magee C; Cheron DM
    J Clin Psychiatry; 2005 Jan; 66(1):52-62. PubMed ID: 15669889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
    Mehta S; Johnson ML; Chen H; Aparasu RR
    J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebro- and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications.
    Jerrell JM; McIntyre RS
    Hum Psychopharmacol; 2007 Aug; 22(6):361-4. PubMed ID: 17562519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental Health Medication Use Correlates with Poor Outcome After Femoroacetabular Impingement Surgery in a Military Population.
    Ernat JJ; Song DJ; Brugman SC; Shaha SH; Tokish JM; Lee GY
    J Bone Joint Surg Am; 2015 Aug; 97(15):1272-7. PubMed ID: 26246262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curaçao Extrapyramidal Syndromes Study XII.
    Mentzel CL; Bakker PR; van Os J; Drukker M; Matroos GE; Hoek HW; Tijssen MA; van Harten PN
    J Clin Psychiatry; 2017 Mar; 78(3):e279-e285. PubMed ID: 28199071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors.
    Saloojee S; Burns JK; Motala AA
    PLoS One; 2016; 11(2):e0149209. PubMed ID: 26882230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review.
    Mangurian C; Newcomer JW; Modlin C; Schillinger D
    J Gen Intern Med; 2016 Sep; 31(9):1083-91. PubMed ID: 27149967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality Risk of Antipsychotic Dose and Duration in Nursing Home Residents with Chronic or Acute Indications.
    Simoni-Wastila L; Wei YJ; Lucas JA; Brandt N; Moyo P; Huang TY; Franey CS; Harris I
    J Am Geriatr Soc; 2016 May; 64(5):973-80. PubMed ID: 27166586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events in elderly users of antipsychotic pharmacotherapy in the province of Manitoba: a retrospective cohort study.
    Vasilyeva I; Biscontri RG; Enns MW; Metge CJ; Alessi-Severini S
    J Clin Psychopharmacol; 2013 Feb; 33(1):24-30. PubMed ID: 23277238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects associated with atypical antipsychotic medications.
    Antai-Otong D
    Perspect Psychiatr Care; 2004; 40(2):70-2. PubMed ID: 15323415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.